GlassScriptPhysician profile
William G Meeks
NPI 1508476375
$1,160.16
in general payments reported to CMS, 2019-2025
19 companies · $245 in 2025
The $245 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $276 · 2022: $277 · 2023: $332 · 2024: $30.58 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $607.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $607.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $264.75 | 2021-2025 | Gardasil 9, Vaxneuvance, Rotateq |
| Corium, LLC | $202.35 | 2022-2023 | Azstarys |
| Tris Pharma INC | $142.48 | 2021-2025 | Dyanavel Xr |
| Glaxosmithkline, LLC. | $112.55 | 2022-2025 | Bexsero |
| Collegium Pharmaceutical, INC. | $55.46 | 2025 | Jornay Pm |
| Ironshore Pharmaceuticals INC. | $46.89 | 2023 | Jornay Pm |
| Pfizer INC. | $44.87 | 2023-2024 | |
| Supernus Pharmaceuticals, INC. | $44.62 | 2022-2023 | Qelbree |
| Astrazeneca Pharmaceuticals LP | $44.29 | 2023 | Flumist Quadrivalent |
| Seqirus USA INC | $34.16 | 2025 | Flucelvax |
| Ultragenyx Pharmaceutical INC. | $31.54 | 2022 | |
| Hologic Sales and Service, LLC | $19.50 | 2023 | Aptima, Third Wave |
| Abbvie INC. | $18.90 | 2021 | |
| Neos Therapeutics, LP | $18.81 | 2021 | |
| Alexion Pharmaceuticals, INC. | $18.24 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $17.64 | 2021 | |
| Neurelis, INC. | $17.45 | 2023 | Valtoco |
| Noven Therapeutics, LLC | $13.78 | 2025 | Xelstrym |
| Teva Pharmaceuticals USA, INC. | $11.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Meeks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.